YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells (2021)
- Authors:
- USP affiliated authors: QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP ; VALERA, ELVIS TERCI - FMRP ; CRUZEIRO, GUSTAVO ALENCASTRO VEIGA - FMRP ; MAGALHÃES, TACIANI DE ALMEIDA - FMRP ; SOUSA, GRAZIELLA RIBEIRO DE - FMRP ; SILVA, RICARDO BONFIM - FMRP ; BIAGI JÚNIOR, CARLOS ALBERTO OLIVEIRA DE - FMRP ; CHAGAS, PABLO FERREIRA DAS - FMRP
- Unidade: FMRP
- DOI: 10.3390/cancers13246249
- Subjects: MEDULOBLASTOMA; GENÔMICA; NEOPLASIAS; BIOMARCADORES; TERAPIA COMBINADA
- Keywords: SHH medulloblastoma; YAP1; SMO inhibitor
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CRUZEIRO, Gustavo Alencastro Veiga et al. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, v. 13, n. 24, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13246249. Acesso em: 28 abr. 2024. -
APA
Cruzeiro, G. A. V., Magalhães, T. de A., Sousa, G. R. de, Silva, R. B., Biagi Junior, C. A. O. de, Chagas, P. F. das, et al. (2021). YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, 13( 24), 1-11. doi:10.3390/cancers13246249 -
NLM
Cruzeiro GAV, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.[citado 2024 abr. 28 ] Available from: https://doi.org/10.3390/cancers13246249 -
Vancouver
Cruzeiro GAV, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.[citado 2024 abr. 28 ] Available from: https://doi.org/10.3390/cancers13246249 - Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors
- The therapeutic potential of Aurora kinases targeting in glioblastoma: from preclinical research to translational oncology
- CTGF expression is indicative of better survival rates in patients with medulloblastoma
- Notch pathway in ependymoma RELA-fused subgroup: upregulation and association with cancer stem cells markers expression
- Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup
- Study adrenocortical tumors in children and adolescent by technique comparative genomic hybridization (CGH)
- Role of SHOC2 gene in the chemotherapy sensibility process in childhood acute lymphoblastic leukemia
- Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ?
- Perfil de expressão dos genes relacionados à migração e adesão celular (TIMP-1, TIMP-2, MMP-2 and MMP-9) em crianças com crianças com leucemia linfóide aguda (LLA): correlação com variáveis clínica e biológica
- Fc'gama' receptor gene polymorphisms in childhood immune thrombocytopenic purpura
Informações sobre o DOI: 10.3390/cancers13246249 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003073627.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
